{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:38:23Z","timestamp":1765355903367},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T00:00:00Z","timestamp":1426291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12943-015-0328-y","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T09:22:44Z","timestamp":1426238564000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAF\n              V600E in melanoma"],"prefix":"10.1186","volume":"14","author":[{"given":"Xingyi","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaomin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,14]]},"reference":[{"key":"328_CR1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","volume":"485","author":"MF Berger","year":"2012","unstructured":"Berger MF, Hodis E, Heffernan TP, Deribe YL, Lawrence MS, Protopopov A, et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature. 2012;485:502\u20136.","journal-title":"Nature"},{"key":"328_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, et al. A landscape of driver mutations in melanoma. Cell. 2012;150:251\u201363.","journal-title":"Cell"},{"key":"328_CR3","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.1304227110","volume":"110","author":"JJ Gartner","year":"2013","unstructured":"Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A. 2013;110:13481\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"328_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949\u201354.","journal-title":"Nature"},{"key":"328_CR5","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24:4340\u20136.","journal-title":"J Clin Oncol"},{"key":"328_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135\u201347.","journal-title":"N Engl J Med"},{"key":"328_CR7","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-13-0804","volume":"13","author":"J Xia","year":"2014","unstructured":"Xia J, Jia P, Hutchinson KE, Dahlman KB, Johnson D, Sosman J, et al. A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance. Mol Cancer Ther. 2014;13:1918\u201328.","journal-title":"Mol Cancer Ther"},{"key":"328_CR8","doi-asserted-by":"publisher","first-page":"e35309","DOI":"10.1371\/journal.pone.0035309","volume":"7","author":"CM Lovly","year":"2012","unstructured":"Lovly CM, Dahlman KB, Fohn LE, Su Z, Dias-Santagata D, Hicks DJ, et al. Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One. 2012;7:e35309.","journal-title":"PLoS One"},{"key":"328_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1479-5876-8-67","volume":"8","author":"JC Rubinstein","year":"2010","unstructured":"Rubinstein JC, Sznol M, Pavlick AC, Ariyan S, Cheng E, Bacchiocchi A, et al. Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. J Transl Med. 2010;8:67.","journal-title":"J Transl Med"},{"key":"328_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nature09627","volume":"468","author":"CM Johannessen","year":"2010","unstructured":"Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature. 2010;468:968\u201372.","journal-title":"Nature"},{"key":"328_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nature09626","volume":"468","author":"R Nazarian","year":"2010","unstructured":"Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010;468:973\u20137.","journal-title":"Nature"},{"key":"328_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","volume":"18","author":"J Villanueva","year":"2010","unstructured":"Villanueva J, Vultur A, Lee JT, Somasundaram R, Fukunaga-Kalabis M, Cipolla AK, et al. Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K. Cancer Cell. 2010;18:683\u201395.","journal-title":"Cancer Cell"},{"key":"328_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nature12688","volume":"504","author":"CM Johannessen","year":"2013","unstructured":"Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature. 2013;504:138\u201342.","journal-title":"Nature"},{"key":"328_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.molonc.2008.01.002","volume":"1","author":"C Kannengiesser","year":"2008","unstructured":"Kannengiesser C, Spatz A, Michiels S, Eychene A, Dessen P, Lazar V, et al. Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas. Mol Oncol. 2008;1:425\u201330.","journal-title":"Mol Oncol"},{"key":"328_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1101\/gr.140061.112","volume":"22","author":"RJ Flockhart","year":"2012","unstructured":"Flockhart RJ, Webster DE, Qu K, Mascarenhas N, Kovalski J, Kretz M, et al. BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res. 2012;22:1006\u201314.","journal-title":"Genome Res"},{"key":"328_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683\u201392.","journal-title":"Cell"},{"key":"328_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","volume":"22","author":"J Sandoval","year":"2012","unstructured":"Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev. 2012;22:50\u20135.","journal-title":"Curr Opin Genet Dev"},{"key":"328_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell. 2012;150:12\u201327.","journal-title":"Cell"},{"key":"328_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2174\/1874091X01105010060","volume":"5","author":"C Rodriguez-Cerdeira","year":"2011","unstructured":"Rodriguez-Cerdeira C, Molares-Vila A. New perspectives of \u201comics\u201d applications in Melanoma research. Open Biochem J. 2011;5:60\u20136.","journal-title":"Open Biochem J"},{"key":"328_CR20","first-page":"89","volume":"2012","author":"K van den Hurk","year":"1826","unstructured":"van den Hurk K, Niessen HE, Veeck J, van den Oord JJ, van Steensel MA, Zur Hausen A, et al. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune. Biochim Biophys Acta. 1826;2012:89\u2013102.","journal-title":"Biochim Biophys Acta"},{"key":"328_CR21","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1158\/2159-8290.CD-13-0424","volume":"4","author":"DJ Konieczkowski","year":"2014","unstructured":"Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA, Piris A, et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 2014;4:816\u201327.","journal-title":"Cancer Discov"},{"key":"328_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, et al. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367:107\u201314.","journal-title":"N Engl J Med"},{"key":"328_CR23","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J, et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012;367:1694\u2013703.","journal-title":"N Engl J Med"},{"key":"328_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1470-2045(12)70269-3","volume":"13","author":"GS Falchook","year":"2012","unstructured":"Falchook GS, Lewis KD, Infante JR, Gordon MS, Vogelzang NJ, DeMarini DJ, et al. Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncol. 2012;13:782\u20139.","journal-title":"Lancet Oncol"},{"key":"328_CR25","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1124\/mol.107.038968","volume":"72","author":"CR Chiaro","year":"2007","unstructured":"Chiaro CR, Patel RD, Marcus CB, Perdew GH. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway. Mol Pharmacol. 2007;72:1369\u201379.","journal-title":"Mol Pharmacol"},{"key":"328_CR26","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1158\/1541-7786.MCR-08-0042","volume":"6","author":"J Borlak","year":"2008","unstructured":"Borlak J, Jenke HS. Cross-talk between aryl hydrocarbon receptor and mitogen-activated protein kinase signaling pathway in liver cancer through c-raf transcriptional regulation. Mol Cancer Res. 2008;6:1326\u201336.","journal-title":"Mol Cancer Res"},{"key":"328_CR27","first-page":"197","volume":"2013","author":"S Feng","year":"1836","unstructured":"Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta. 1836;2013:197\u2013210.","journal-title":"Biochim Biophys Acta"},{"key":"328_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1158\/0008-5472.CAN-09-3090","volume":"70","author":"Y Fan","year":"2010","unstructured":"Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res. 2010;70:212\u201320.","journal-title":"Cancer Res"},{"key":"328_CR29","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-12-1632","volume":"18","author":"JS Khalili","year":"2012","unstructured":"Khalili JS, Liu S, Rodriguez-Cruz TG, Whittington M, Wardell S, Liu C, et al. Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma. Clin Cancer Res. 2012;18:5329\u201340.","journal-title":"Clin Cancer Res"},{"key":"328_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-2187-9-8","volume":"9","author":"AO Adefuye","year":"2014","unstructured":"Adefuye AO, Sales KJ, Katz AA. Seminal plasma induces the expression of IL-1alpha in normal and neoplastic cervical cells via EP2\/EGFR\/PI3K\/AKT pathway. J Mol Signal. 2014;9:8.","journal-title":"J Mol Signal"},{"key":"328_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s10753-014-9874-5","volume":"37","author":"X Liu","year":"2014","unstructured":"Liu X, Ye F, Xiong H, Hu D, Limb GA, Xie T, et al. IL-1beta Upregulates IL-8 Production in Human Muller Cells Through Activation of the p38 MAPK and ERK1\/2 Signaling Pathways. Inflammation. 2014;37:1486\u201395.","journal-title":"Inflammation"},{"key":"328_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1476-4598-11-79","volume":"11","author":"L Ma","year":"2012","unstructured":"Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu W, et al. Epidermal growth factor (EGF) and interleukin (IL)-1beta synergistically promote ERK1\/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer. 2012;11:79.","journal-title":"Mol Cancer"},{"key":"328_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF00133480","volume":"13","author":"M Saito","year":"1995","unstructured":"Saito M, Fan D, Lachman LB. Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice. Clin Exp Metastasis. 1995;13:249\u201359.","journal-title":"Clin Exp Metastasis"},{"key":"328_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0959-8049(94)90317-4","volume":"30A","author":"E Tartour","year":"1994","unstructured":"Tartour E, Adams D, Besancenot JF, Fridman WH, Schlumberger M. Poems syndrome with high interleukin (IL)6 and IL1 beta serum levels, in a patient with thyroid carcinoma and melanoma. Eur J Cancer. 1994;30A:893\u20134.","journal-title":"Eur J Cancer"},{"key":"328_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature03664","volume":"436","author":"LA Garraway","year":"2005","unstructured":"Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117\u201322.","journal-title":"Nature"},{"key":"328_CR36","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1083\/jcb.200505059","volume":"170","author":"C Wellbrock","year":"2005","unstructured":"Wellbrock C, Marais R. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol. 2005;170:703\u20138.","journal-title":"J Cell Biol"},{"key":"328_CR37","doi-asserted-by":"publisher","first-page":"e2734","DOI":"10.1371\/journal.pone.0002734","volume":"3","author":"C Wellbrock","year":"2008","unstructured":"Wellbrock C, Rana S, Paterson H, Pickersgill H, Brummelkamp T, Marais R. Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF. PLoS One. 2008;3:e2734.","journal-title":"PLoS One"},{"key":"328_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/sj.bjc.6690339","volume":"80","author":"M Matsushita","year":"1999","unstructured":"Matsushita M, Matsuzaki K, Date M, Watanabe T, Shibano K, Nakagawa T, et al. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer. 1999;80:194\u2013205.","journal-title":"Br J Cancer"},{"key":"328_CR39","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1093\/carcin\/bgq155","volume":"31","author":"A Lasfar","year":"2010","unstructured":"Lasfar A, Cohen-Solal KA. Resistance to transforming growth factor beta-mediated tumor suppression in melanoma: are multiple mechanisms in place? Carcinogenesis. 2010;31:1710\u20137.","journal-title":"Carcinogenesis"},{"key":"328_CR40","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1200\/JCO.2005.02.047","volume":"23","author":"RL Elliott","year":"2005","unstructured":"Elliott RL, Blobe GC. Role of transforming growth factor Beta in human cancer. J Clin Oncol. 2005;23:2078\u201393.","journal-title":"J Clin Oncol"},{"key":"328_CR41","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/onc.2010.612","volume":"30","author":"T Strub","year":"2011","unstructured":"Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, et al. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene. 2011;30:2319\u201332.","journal-title":"Oncogene"},{"key":"328_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","volume":"4","author":"TJ Parmenter","year":"2014","unstructured":"Parmenter TJ, Kleinschmidt M, Kinross KM, Bond ST, Li J, Kaadige MR, et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov. 2014;4:423\u201333.","journal-title":"Cancer Discov"},{"key":"328_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4161\/cc.11.2.18707","volume":"11","author":"P Hou","year":"2012","unstructured":"Hou P, Liu D, Dong J, Xing M. The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells. Cell Cycle. 2012;11:286\u201395.","journal-title":"Cell Cycle"},{"key":"328_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1074\/jbc.M109.068668","volume":"285","author":"N Maddodi","year":"2010","unstructured":"Maddodi N, Bhat KM, Devi S, Zhang SC, Setaluri V. Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1. J Biol Chem. 2010;285:242\u201354.","journal-title":"J Biol Chem"},{"key":"328_CR45","doi-asserted-by":"publisher","first-page":"12372","DOI":"10.1073\/pnas.1109363108","volume":"108","author":"HW Cheung","year":"2011","unstructured":"Cheung HW, Cowley GS, Weir BA, Boehm JS, Rusin S, Scott JA, et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A. 2011;108:12372\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"328_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3(1):1\u201325.","journal-title":"Stat Appl Genet Mol Biol"},{"key":"328_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"328_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research N","year":"2011","unstructured":"Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"},{"key":"328_CR49","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/bioinformatics\/btu603","volume":"31","author":"Y Xu","year":"2015","unstructured":"Xu Y, Guo X, Sun J, Zhao Z. Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation. Bioinformatics. 2015;31:84\u201393.","journal-title":"Bioinformatics"},{"key":"328_CR50","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1073\/pnas.1205575110","volume":"110","author":"R Haq","year":"2013","unstructured":"Haq R, Yokoyama S, Hawryluk EB, Jonsson GB, Frederick DT, McHenry K, et al. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A. 2013;110:4321\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"328_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic Melanoma. Cancer Discov. 2014;4:94\u2013109.","journal-title":"Cancer Discov"},{"key":"328_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ccr.2013.05.009","volume":"24","author":"M Saez-Ayala","year":"2013","unstructured":"Saez-Ayala M, Montenegro MF, Sanchez-Del-Campo L, Fernandez-Perez MP, Chazarra S, Freter R, et al. Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell. 2013;24:105\u201319.","journal-title":"Cancer Cell"},{"key":"328_CR53","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/sj.onc.1206461","volume":"22","author":"E Sharpless","year":"2003","unstructured":"Sharpless E, Chin L. The INK4a\/ARF locus and melanoma. Oncogene. 2003;22:3092\u20138.","journal-title":"Oncogene"},{"key":"328_CR54","doi-asserted-by":"publisher","first-page":"e25168","DOI":"10.1371\/journal.pone.0025168","volume":"6","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Chen L, Helfand BT, Jang TL, Sharma V, Kozlowski J, et al. TGF-beta regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One. 2011;6:e25168.","journal-title":"PLoS One"},{"key":"328_CR55","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-015-0328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-015-0328-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-015-0328-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-015-0328-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:25:29Z","timestamp":1630574729000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-015-0328-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1186\/s12943-015-0328-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,14]]},"assertion":[{"value":"28 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}